WUXI APPTEC News

WUXI APPTEC(603259):STEADY 1Q PERFORMANCE AMID CHALLENGING ENVIRONMENT

招银国际May 2 13:06

Yao Ming Kangde (603259): Revenue in Europe and the US is still growing steadily, and the TIDES business is expanding rapidly

民生證券May 1 07:36

Yao Ming Kangde (603259): Molecular pipelines continue to expand and the new molecule business continues to expand

中金公司May 1 00:00

Yao Ming Kangde (603259): Steady growth in performance and continuous improvement of production and operation efficiency

廣發證券Apr 30 17:11

UBS: Maintaining the “neutral” rating of Pharmacovigilance (02359), the target price was reduced to HK$40.1

Zhitong FinanceApr 30 11:26

Yao Ming Kang De (603259): Optimistic about the 24-year trend

華泰證券Apr 30 10:46

Yao Ming Kangde (603259): The COVID-19 base disrupts Q1 and the non-COVID-19 business is expected to continue to grow steadily throughout the year

中泰證券Apr 30 00:00

Pharmaceutical Kangde (603259): Regular business growth is strong, integration advantages are highlighted

東北證券Apr 24 00:00

Yao Ming Kangde (603259): Backend maintains high growth and TIDES business continues to expand

長江證券Mar 31 00:00

Yao Ming Kangde (603259) Company Brief Evaluation Report: Steady Growth in Performance, Outstanding Business Performance by TIDES

首創證券Mar 28 00:00

Yao Ming Kangde (603259): Revenue and profit increased steadily throughout the year, and TIDES business orders increased significantly

海通證券Mar 27 07:32

Yao Ming Kangde (603259): 23-year performance achieved steady growth, D&M business continues to contribute to performance growth

華西證券Mar 27 00:00

Yao Ming Kangde (603259): Integrated platforms drive steady business growth and are optimistic about long-term development prospects

中信建投證券Mar 26 16:12

Yao Ming Kangde (603259) 2023 Report Review: Year-round revenue and profit increased steadily, and TIDES business orders increased significantly

海通國際Mar 26 00:00

Yao Ming Kangde (603259): Performance is in line with expectations, strong growth in the new molecule business

東方證券Mar 25 20:46

Yao Ming Kangde (603259): Steady growth in performance, and the peptide business continues to gain strength

國泰君安Mar 25 13:11

Yao Ming Kang De (603259): Optimistic about integrated toughness under disturbances

浙商證券Mar 25 00:00

Yao Ming Kangde (603259): Performance is in line with expectations and has maintained steady growth for 24 years

財通證券Mar 21 19:21

Yao Ming Kangde (603259) 2023 Annual Report Review: Performance is in line with expectations, TIDES business is growing rapidly

西部證券Mar 21 07:21

Yao Ming Kangde (603259): Forward-looking layout highlights management resilience and continuous improvement in operating efficiency

廣發證券Mar 21 00:00